Bibliographic Details
| Title: |
Atopic Dermatitis Activity Score 7 (ADAS7): A tool for disease activity assessment. |
| Authors: |
De Greef, Axel1,2 (AUTHOR) axel.degreef@saintluc.uclouvain.be, Degraeuwe, Alexia1 (AUTHOR), Nielens, Nina1 (AUTHOR), Darrigade, Anne‐Sophie1 (AUTHOR), Bugli, Céline3 (AUTHOR), de Montjoye, Laurence1,2 (AUTHOR), Baeck, Marie1,2 (AUTHOR) |
| Source: |
Clinical & Translational Allergy. Sep2024, Vol. 14 Issue 9, p1-3. 3p. |
| Subject Terms: |
*PATIENT satisfaction, *PATIENT selection, *INTRACLASS correlation, *ATOPIC dermatitis, *MERGERS & acquisitions, *SOCIAL dynamics, *SELECTION bias (Statistics) |
| Abstract: |
The article discusses the development and validation of a new scoring system called the Atopic Dermatitis Activity Score 7 (ADAS7) for assessing disease activity in patients with atopic dermatitis (AD). The ADAS7 score combines clinical signs, patient-reported symptoms, and quality of life measures. The study found that ADAS7 correlated well with the existing scoring system, SCORing Atopic Dermatitis (SCORAD), and was able to identify patients with controlled AD, non-controlled AD with continuously severe disease, and non-controlled AD with active (fluctuating) disease. The limitations of the study include a small sample size and potential selection bias due to loss-to-follow-up. The authors suggest that ADAS7 can be a useful tool for discussing long-term disease control and treatment strategies with patients. [Extracted from the article] |
|
Copyright of Clinical & Translational Allergy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
